Patrick Vermersch

Lille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 234 publications

Long-term efficacy of cladribine tablets: Results from the MAGNIFY-MS Extension study.

Long-term efficacy of cladribine tablets: Results from the MAGNIFY-MS Extension study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 04, 2026

French expert opinion on the long-term management of relapsing multiple sclerosis with cladribine tablets beyond year 4.

French expert opinion on the long-term management of relapsing multiple sclerosis with cladribine tablets beyond year 4.

Journal: Journal of neurology

Published: June 15, 2026

A plain language summary on clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS study.

A plain language summary on clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS study.

Journal: Neurodegenerative disease management

Published: April 07, 2026

Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosis.

Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosis.

Journal: Frontiers in immunology

Published: March 17, 2026

A Qualitative Study of Lived Treatment Experiences and Preferences of Long-Term DMT Users with Relapsing-Remitting Multiple Sclerosis.

A Qualitative Study of Lived Treatment Experiences and Preferences of Long-Term DMT Users with Relapsing-Remitting Multiple Sclerosis.

Journal: Neurology and therapy

Published: March 12, 2026

A clustering-based approach to characterize autonomy profiles among multiple sclerosis patients: an application of the Qluster method in the FOCAL-MS2 study.

A clustering-based approach to characterize autonomy profiles among multiple sclerosis patients: an application of the Qluster method in the FOCAL-MS2 study.

Journal: Journal of patient-reported outcomes

Published: February 24, 2026

Validation and psychometric properties of the Multiple Sclerosis Autonomy Score (MSAS) in a French cohort: The FOCAL-MS 2 study.

Validation and psychometric properties of the Multiple Sclerosis Autonomy Score (MSAS) in a French cohort: The FOCAL-MS 2 study.

Journal: Multiple sclerosis and related disorders

Published: February 24, 2026

Patient-reported outcomes and multiple sclerosis therapies.

Patient-reported outcomes and multiple sclerosis therapies.

Journal: The Lancet. Neurology

Published: November 27, 2025

Efficacy and Safety of Patients With Relapsing Multiple Sclerosis Switching to Ocrelizumab Due to Suboptimal Treatment Response: Results of the 4-Year CASTING-LIBERTO Trial.

Efficacy and Safety of Patients With Relapsing Multiple Sclerosis Switching to Ocrelizumab Due to Suboptimal Treatment Response: Results of the 4-Year CASTING-LIBERTO Trial.

Journal: European journal of neurology

Published: November 11, 2025

Digital patient experience tools in multiple sclerosis: a landscape analysis of the global Patient-Reported Outcomes in Multiple Sclerosis (PROMS) initiative.

Digital patient experience tools in multiple sclerosis: a landscape analysis of the global Patient-Reported Outcomes in Multiple Sclerosis (PROMS) initiative.

Journal: EClinicalMedicine

Published: September 13, 2025

Progression to Wheelchair in Secondary Progressive Multiple Sclerosis and Impact of Siponimod: Post Hoc Analyses From the EXPAND Study.

Progression to Wheelchair in Secondary Progressive Multiple Sclerosis and Impact of Siponimod: Post Hoc Analyses From the EXPAND Study.

Journal: European journal of neurology

Published: September 10, 2025

Directions for advancing prognostic assessments in multiple sclerosis: Qualitative Insights from MS specialist Interviews.

Directions for advancing prognostic assessments in multiple sclerosis: Qualitative Insights from MS specialist Interviews.

Journal: Journal of the neurological sciences

Published: August 25, 2025

Showing 1-12 of 234

Last Updated: 09/26/2026